About this trial
The current study aims to assess the influence of different scaffolds on postoperative pain and success rate of pulpotomy in mandibular mature molars with symptomatic irreversible pulpitis
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ASA I patients who are free from any physical or mental handicapping condition with no underlying systemic disease.
Age between 15-40 years.
Males & Females.
Patients' acceptance to participate in the trial.
Disqualifiers
Pregnant and lactating females.
Patients with physical or mental handicapping conditions.
Patients unwilling to participate in a 12-months follow up.
Immature roots.
Trial design
Parallel
Treatments tested in this trial
Regenerative pulpotomy
Procedure/SurgeryRegenerative pulpotomy combines the use of hydraulic calcium silicate based cements; MTA, together with biodegradable scaffolds such as PRF.
Treatment groups
Trial outcomes
Primary outcomes
Intensity of postoperative pain
measured using numerical rating scale
Secondary outcomes
Overall success rate
Based on clinical and radiographic signs and symptoms
IL-8 and TNF-α levels in pulpal blood
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: